Back
Paragon 28 Vs. Perspective Therapeutics Industry Stock Comparison
Buy
97
FNA
Paragon 28
Last Price:
9.72
Seasonality Move:
7.65%
Sell
30
CATX
Perspective Therapeutics
Last Price:
8.92
Seasonality Move:
28.97%
Buy
97
Paragon 28 (FNA)
is a Buy
Is Paragon 28 a Buy, Sell or Hold?
- The current Paragon 28 [FNA] share price is $10.30. The Score for FNA is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- FNA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FNA Stock Price Chart
What is Paragon 28's stock price today?
-
The Paragon 28 share price today is $10.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $9.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
FNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 83.48 | Buy |
| Chaikin Money Flow: | 1978165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.8 - 7.22) | Buy |
| Bollinger Bands (100): | (5.9 - 8.14) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 28.07 | Sell |
| Chaikin Money Flow: | -952055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.27 - 12.77) | Sell |
| Bollinger Bands (100): | (11.25 - 14.33) | Sell |
FNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.4 | Buy |
| 20-day SMA: | 6.11 | Buy |
| 50-day SMA: | 6.38 | Buy |
| 200-day SMA: | 8.53 | Buy |
| 8-day EMA: | 7.64 | Buy |
| 20-day EMA: | 6.68 | Buy |
| 50-day EMA: | 6.55 | Buy |
| 200-day EMA: | 8.35 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.45 | Sell |
| 20-day SMA: | 11.83 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 11.13 | Sell |
| 20-day EMA: | 11.74 | Sell |
| 50-day EMA: | 12.46 | Sell |
| 200-day EMA: | 11.73 | Sell |
Paragon 28 Earnings Growth & FNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.17 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.
Paragon 28 Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||